181 related articles for article (PubMed ID: 15090102)
1. Predicting EuroQoL EQ-5D preference scores from the SF-12 Health Survey in a nationally representative sample.
Lawrence WF; Fleishman JA
Med Decis Making; 2004; 24(2):160-9. PubMed ID: 15090102
[TBL] [Abstract][Full Text] [Related]
2. EQ-5D and SF-36 quality of life measures in systemic lupus erythematosus: comparisons with rheumatoid arthritis, noninflammatory rheumatic disorders, and fibromyalgia.
Wolfe F; Michaud K; Li T; Katz RS
J Rheumatol; 2010 Feb; 37(2):296-304. PubMed ID: 20032098
[TBL] [Abstract][Full Text] [Related]
3. Estimating EuroQol EQ-5D scores from Population Healthy Days data.
Jia H; Lubetkin EI
Med Decis Making; 2008; 28(4):491-9. PubMed ID: 18556640
[TBL] [Abstract][Full Text] [Related]
4. An investigation into the empirical validity of the EQ-5D and SF-6D based on hypothetical preferences in a general population.
Petrou S; Hockley C
Health Econ; 2005 Nov; 14(11):1169-89. PubMed ID: 15942981
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the EuroQol and short form 6D in Singapore multiethnic Asian knee osteoarthritis patients scheduled for total knee replacement.
Xie F; Li SC; Luo N; Lo NN; Yeo SJ; Yang KY; Fong KY; Thumboo J
Arthritis Rheum; 2007 Aug; 57(6):1043-9. PubMed ID: 17665466
[TBL] [Abstract][Full Text] [Related]
6. Rapid and sustained improvement in health-related quality of life and utility for 72 weeks in patients with ankylosing spondylitis receiving etanercept.
Boonen A; Patel V; Traina S; Chiou CF; Maetzel A; Tsuji W
J Rheumatol; 2008 Apr; 35(4):662-7. PubMed ID: 18278836
[TBL] [Abstract][Full Text] [Related]
7. A comparison of SF-6D and EQ-5D utility scores in a study of patients with schizophrenia.
McCrone P; Patel A; Knapp M; Schene A; Koeter M; Amaddeo F; Ruggeri M; Giessler A; Puschner B; Thornicroft G
J Ment Health Policy Econ; 2009 Mar; 12(1):27-31. PubMed ID: 19346564
[TBL] [Abstract][Full Text] [Related]
8. The validity of EQ-5D US preference weights in liver transplant candidates and recipients.
Russell RT; Feurer ID; Wisawatapnimit P; Pinson CW
Liver Transpl; 2009 Jan; 15(1):88-95. PubMed ID: 19109831
[TBL] [Abstract][Full Text] [Related]
9. The impact of obesity on health-related quality-of-life in the general adult US population.
Jia H; Lubetkin EI
J Public Health (Oxf); 2005 Jun; 27(2):156-64. PubMed ID: 15820993
[TBL] [Abstract][Full Text] [Related]
10. Psychometric properties of the EuroQol-5D and Short Form-6D in patients with systemic lupus erythematosus.
Aggarwal R; Wilke CT; Pickard AS; Vats V; Mikolaitis R; Fogg L; Block JA; Jolly M
J Rheumatol; 2009 Jun; 36(6):1209-16. PubMed ID: 19369452
[TBL] [Abstract][Full Text] [Related]
11. Using the SF-12 health status measure to improve predictions of medical expenditures.
Fleishman JA; Cohen JW; Manning WG; Kosinski M
Med Care; 2006 May; 44(5 Suppl):I54-63. PubMed ID: 16625065
[TBL] [Abstract][Full Text] [Related]
12. Assessing utility values in rheumatoid arthritis: a comparison between time trade-off and the EuroQol.
Ariza-Ariza R; Hernández-Cruz B; Carmona L; Dolores Ruiz-Montesinos M; Ballina J; Navarro-Sarabia F;
Arthritis Rheum; 2006 Oct; 55(5):751-6. PubMed ID: 17013822
[TBL] [Abstract][Full Text] [Related]
13. Impact of cardiometabolic risk factor clusters on health-related quality of life in the U.S.
Sullivan PW; Ghushchyan V; Wyatt HR; Wu EQ; Hill JO
Obesity (Silver Spring); 2007 Feb; 15(2):511-21. PubMed ID: 17299125
[TBL] [Abstract][Full Text] [Related]
14. A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis.
Marra CA; Woolcott JC; Kopec JA; Shojania K; Offer R; Brazier JE; Esdaile JM; Anis AH
Soc Sci Med; 2005 Apr; 60(7):1571-82. PubMed ID: 15652688
[TBL] [Abstract][Full Text] [Related]
15. Preference-based quality of life in patients with Alzheimer's disease.
Karlawish JH; Zbrozek A; Kinosian B; Gregory A; Ferguson A; Glick HA
Alzheimers Dement; 2008 May; 4(3):193-202. PubMed ID: 18631968
[TBL] [Abstract][Full Text] [Related]
16. Comparing the EQ-5D and the SF-6D descriptive systems to assess their ceiling effects in the US general population.
Bharmal M; Thomas J
Value Health; 2006; 9(4):262-71. PubMed ID: 16903996
[TBL] [Abstract][Full Text] [Related]
17. Utilities should not be multiplied: evidence from the preference-based scores in the United States.
Fu AZ; Kattan MW
Med Care; 2008 Sep; 46(9):984-90. PubMed ID: 18725854
[TBL] [Abstract][Full Text] [Related]
18. Mapping the EQ-5D index from the SF-12: US general population preferences in a nationally representative sample.
Sullivan PW; Ghushchyan V
Med Decis Making; 2006; 26(4):401-9. PubMed ID: 16855128
[TBL] [Abstract][Full Text] [Related]
19. Relative disutilities of 47 risk factors and conditions assessed with seven preference-based health status measures in a national U.S. sample: toward consistency in cost-effectiveness analyses.
Franks P; Hanmer J; Fryback DG
Med Care; 2006 May; 44(5):478-85. PubMed ID: 16641667
[TBL] [Abstract][Full Text] [Related]
20. Potentially inappropriate drug use and health-related quality of life in the elderly.
Franic DM; Jiang JZ
Pharmacotherapy; 2006 Jun; 26(6):768-78. PubMed ID: 16716130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
